Gombe, B, Streatfield, C, Leal, L, Opio, S, Joseph, S, Weber, J, Hare, J, Kaleebu, P and Serwanga, J. 2022. Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data. [Online]. PLOS ONE. Available from: https://doi.org/10.1371/journal.pone.0275927.s001
Gombe, B, Streatfield, C, Leal, L, Opio, S, Joseph, S, Weber, J, Hare, J, Kaleebu, P and Serwanga, J. Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data [Internet]. PLOS ONE; 2022. Available from: https://doi.org/10.1371/journal.pone.0275927.s001
Gombe, B, Streatfield, C, Leal, L, Opio, S, Joseph, S, Weber, J, Hare, J, Kaleebu, P and Serwanga, J (2022). Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data. [Data Collection]. PLOS ONE. https://doi.org/10.1371/journal.pone.0275927.s001
Description
Data supporting the analyses outlined in "Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial".
| Data capture method | Unknown |
|---|---|
| Date (Date published in a 3rd party system) | 3 November 2022 |
| Language(s) of written materials | English |
| Data Creators | Gombe, B, Streatfield, C, Leal, L, Opio, S, Joseph, S, Weber, J, Hare, J, Kaleebu, P and Serwanga, J |
|---|---|
| LSHTM Faculty/Department | MRC/UVRI and LSHTM Uganda Research Unit |
| Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom |
| Date Deposited | 09 Dec 2022 11:41 |
|---|---|
| Last Modified | 09 Dec 2022 11:41 |
| Publisher | PLOS ONE |
